Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
The Axcelis Technologies Inc (ACLS) news page on Stock Titan aggregates company announcements, industry event participation and regulatory disclosures focused on its role in the semiconductor equipment market. Axcelis describes itself as a leading supplier of enabling ion implantation solutions for the semiconductor industry, with more than 45 years of experience providing high-productivity systems and lifecycle support.
Investors and industry followers can use this page to monitor Axcelis’ updates on product launches, technology platforms and market engagement. Recent news has highlighted the introduction of the Purion Power Series+ ion implant platform for next generation power devices, including silicon carbide (SiC) power devices and superjunction architectures, as well as the GSD Ovation ES high current implanter for engineered substrates. Company releases also cover its participation in major industry events such as SEMICON Japan and the International Conference on Silicon Carbide and Related Materials (ICSCRM), where Axcelis technologists present technical work on SiC and related materials.
The feed also includes financial and corporate developments, such as quarterly results announcements, conference call schedules and Axcelis’ participation in investor conferences. A significant recent development is the all-stock merger agreement with Veeco Instruments Inc., under which Veeco is expected to become a wholly owned subsidiary of Axcelis, subject to regulatory and shareholder approvals.
By following this ACLS news page, readers can track Axcelis’ communications on its ion implantation product portfolio, aftermarket strategy, global customer engagement and planned combination with Veeco, all drawn from official press releases and SEC-referenced materials.
Axcelis Technologies (NASDAQ: ACLS) reported Q3 2024 financial results with revenue of $256.6 million, slightly up from $256.5 million in Q2. Operating profit decreased to $46.9 million from $52.8 million, while net income fell to $48.6 million ($1.49 per diluted share) from $50.9 million ($1.55 per share). Gross margin declined to 42.9% from 43.8%. The company expects Q4 2024 revenues of approximately $245 million with EPS of $1.25. Additionally, Axcelis corrected historical backlog figures, with Q2 2024 backlog revised to $879 million from previously reported $994 million. Q3 2024 backlog stands at $758 million.
Axcelis Technologies (Nasdaq: ACLS), a leading supplier of ion implantation solutions for the semiconductor industry, has announced the timing for its third quarter 2024 financial results. The company will release its Q3 2024 results on Wednesday, November 6, 2024, at 4:00 p.m. ET.
Following the release, Axcelis will host a conference call to discuss the results on Thursday, November 7, 2024, at 8:30 a.m. ET. Investors and interested parties can access the call via a webcast through the Investors page of Axcelis' website or by registering as a participant through a provided link. The webcast replay will be available for 30 days after the call.
Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of ion implantation solutions for the semiconductor industry, has announced its participation in the International Conference on Silicon Carbide and Related Materials (ICSCRM 2024). The event will take place from September 29 to October 4, 2024, at the Raleigh Convention Center in North Carolina. Axcelis' management will be available for one-on-one meetings during the conference.
Dr. Russell Low, President and CEO of Axcelis, expressed excitement about participating in ICSCRM 2024, describing it as one of the most important technology forums in the power market. He highlighted the company's Purion™ Power Series as the technology leader in this market, citing its enabling and highly differentiated features and process control. Dr. Low also emphasized the critical role of ion implant in manufacturing Silicon Carbide devices, a market estimated by Yole to grow at a 25% CAGR from 2023 to 2029.
Axcelis Technologies (NASDAQ: ACLS) announced its Platinum Sponsorship of the International Conference on Ion Implantation Technology 2024 (IIT 2024) in Toyama, Japan. The event, scheduled for September 23-26, focuses on challenges in implant/doping and annealing processes, device applications, equipment, metrology, and modeling. Axcelis will host an exhibit and present nine topics, including performance of aluminum sputtering sources, energetic metals characterization, radiation mitigation, and innovations in wide bandgap materials.
CEO Russell Low emphasized the importance of the Japanese market for Axcelis, noting recent openings of new Service Centers in Japan. The company aims to grow its global market share by providing innovative implant technology and support solutions.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the inaugural SEMICON India 2024, showcasing its Purion™ and GSD Ovation™ Series of ion implanters. The event will be held from September 11-13 at the India Expo Mart in Greater Noida, Delhi. Axcelis will exhibit in Booth #H1T11, featuring innovative ion implant solutions that offer significant technology and manufacturing advantages.
The showcase includes the Purion Power Series™ for thin silicon, TAIKO, and SiC wafer processing; the Purion H Series for high current implants; the Purion XE Series for high energy implants; and the GSD Ovation™ for cost-effective batch platform capability. CEO Russell Low highlighted the importance of the Indian semiconductor market, projected to reach over $55 billion by 2026, driven by smartphones, automotive components, and computing sectors.
Axcelis Technologies (NASDAQ: ACLS), a key player in ion implantation solutions for the semiconductor industry, announced its participation in several upcoming investor conferences.
August 22nd: 5th Annual Needham Virtual Semiconductor & SemiCap 1x1 Conference.
August 27th: Jefferies Semiconductor, IT Hardware, Communications Software and Infrastructure Summit at the Four Seasons Hotel, Chicago, IL.
August 28th: Evercore ISI 2024 Semiconductor, IT Hardware & Networking Conference at the Omni Chicago.
September 4th: Benchmark 2024 Tech/Media/Telecom Conference at the New York Athletic Club.
September 12th: B. Riley Securities Consumer & TMT Conference at the Sofitel, New York.
Management will be available for one-on-ones and small group meetings at these events.
Axcelis Technologies (NASDAQ: ACLS) reported strong Q2 2024 financial results, with revenue of $256.5 million, up from $252.4 million in Q1. The company's operating margin was 20.6%, with diluted EPS of $1.55. Gross margin decreased slightly to 43.8% from 46.0% in Q1. CEO Russell Low highlighted better-than-expected conversion of evaluation units and robust demand in the Power segment, particularly in silicon carbide. For Q3 2024, Axcelis expects revenues of approximately $255 million and EPS of about $1.43. The company anticipates revenue in the second half of 2024 to be slightly better than the first half, with momentum building into 2025.
Axcelis Technologies (Nasdaq: ACLS), a leading supplier of ion implantation solutions for the semiconductor industry, has announced the timing for its second quarter 2024 financial results. The company will release its Q2 2024 results on Wednesday, July 31, 2024, at 4:00 p.m. ET. Following this, Axcelis will host a conference call to discuss these results on Thursday, August 1, 2024, at 8:30 a.m. ET.
Interested parties can access the call via an audio webcast on the Investors page of Axcelis' website or by registering as a participant through a provided link. The webcast replay will be available for 30 days after the call.
Axcelis Technologies, a key supplier in the semiconductor industry, announced preliminary Q2 2024 financial results ahead of an investor event. The company expects revenue to surpass $252 million, exceeding prior guidance of $245 million. Diluted earnings per share (EPS) are anticipated to be over $1.38, compared to the previous estimate of $1.30. CEO Russell Low attributed the strong performance to robust demand for the Purion platform. Axcelis projects a stronger second half of 2024, with a slight emphasis on Q4. Final Q2 results will be released on July 31, 2024.
Axcelis Technologies (Nasdaq: ACLS) has announced the appointment of David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, effective July 2024. Ryzhik brings over 20 years of experience in investor relations and finance, including roles at MKS Instruments and Susquehanna International Group. He will succeed Doug Lawson, who plans to retire but will remain as a Senior Advisor until July 2025. Lawson has had a 15-year tenure with Axcelis, holding various executive roles and significantly contributing to corporate marketing and strategy. The transition aims to leverage Ryzhik's extensive experience to further Axcelis' growth objectives.